Novel Flowmeter Streamlines Urine Flow Screening
|
By HospiMedica International staff writers Posted on 16 Nov 2021 |
|
Image: The Oruflow fully automated, contactless, uroflowmetry device (Photo courtesy of Oruba)
An innovative self-operating device measures urine flow rate, providing important indicators for lower urinary tract symptoms (LUTS).
The Oruba (Ankara, Turkey) Oruflow is a fully automated, contactless, uroflowmetry device that requires no human intervention for function and sanitation. It has a built-in barcode scanner that registers the patient and collects all necessary information; textual, audio, and visual tutorials on using the device to ensure that the patient is adequately informed; and self-cleaning and sanitizing, preparing the device for use by the next patient in under a minute.
The internet-of-things (IoT)-supported uroflowmeter is designed to increase patient comfort and privacy. Oruflow starts the screening automatically, prepares a report while the patient is finishing up, prints it out for patient convenience, and also sends a digital version to the hospital information system (HIS). For clinics that do not use a barcode scanner, registration can be completed through Oruflow software, which can be used on any device with an internet connection; test results can also be examined on those devices.
“Oruba is a technology-focused startup with an interdisciplinary team of computer, electronics, mechanical and biomedical engineering, physics, industrial design, urology, and emergency care specialists,” stated the company. “Oruba is devoted to creating advanced medical devices that capture all bioinformation in human excreta. We are constantly working to develop innovations that can be highly scalable and have not been developed and in the world.”
Uroflowmetry is an essential tool to assess bladder and sphincter function. It requires the patient to urinate into a funnel-shaped device to measure amount of urine passed, urination speed (expressed in milliliters per second), and the length of time it takes to empty the whole bladder. Flow rates can help determine potential existence of diseases, such as benign prostate hyperplasia (BPH), bladder cancer, prostate cancer, neurogenic bladder dysfunction, and urinary blockage.
Related Links:
Oruba
The Oruba (Ankara, Turkey) Oruflow is a fully automated, contactless, uroflowmetry device that requires no human intervention for function and sanitation. It has a built-in barcode scanner that registers the patient and collects all necessary information; textual, audio, and visual tutorials on using the device to ensure that the patient is adequately informed; and self-cleaning and sanitizing, preparing the device for use by the next patient in under a minute.
The internet-of-things (IoT)-supported uroflowmeter is designed to increase patient comfort and privacy. Oruflow starts the screening automatically, prepares a report while the patient is finishing up, prints it out for patient convenience, and also sends a digital version to the hospital information system (HIS). For clinics that do not use a barcode scanner, registration can be completed through Oruflow software, which can be used on any device with an internet connection; test results can also be examined on those devices.
“Oruba is a technology-focused startup with an interdisciplinary team of computer, electronics, mechanical and biomedical engineering, physics, industrial design, urology, and emergency care specialists,” stated the company. “Oruba is devoted to creating advanced medical devices that capture all bioinformation in human excreta. We are constantly working to develop innovations that can be highly scalable and have not been developed and in the world.”
Uroflowmetry is an essential tool to assess bladder and sphincter function. It requires the patient to urinate into a funnel-shaped device to measure amount of urine passed, urination speed (expressed in milliliters per second), and the length of time it takes to empty the whole bladder. Flow rates can help determine potential existence of diseases, such as benign prostate hyperplasia (BPH), bladder cancer, prostate cancer, neurogenic bladder dysfunction, and urinary blockage.
Related Links:
Oruba
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Medical-Grade Display
HL2316SHTB
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
